(*contributed equally to this work) 发布: 2016年06月05日第6卷第11期 DOI: 10.21769/BioProtoc.1829 浏览次数: 15020
评审: Ivan ZanoniMigla MiskinyteAnonymous reviewer(s)
Abstract
The human monoclonal antibodies generated from single human B cells were tested to characterize their ability to neutralize virus infectivity. The microneutralization assay is a highly sensitive and specific assay for detecting virus-specific neutralizing antibodies to influenza viruses. This protocol is to measure the ability of human monoclonal antibody to neutralize influenza virus by microneutralization assay.
Materials and Reagents
Equipment
Procedure
文章信息
版权信息
© 2016 The Authors; exclusive licensee Bio-protocol LLC.
如何引用
Wu, Y., Cho, M., Shore, D., Song, M., Choi, J., Jiang, T., Deng, Y., Bourgeois, M., Almli, L., Yang, H., Chen, L., Shi, Y., Qi, J., Li, A., Yi, K. S., Chang, M., Bae, J. S., Lee, H., Shin, J., Stevens, J., Hong, S., Qin, C., Gao, G. F., Chang, S. J. and Donis, R. O. (2016). Micro Neutralization (MN) Assay of Influenza Viruses with Monoclonal Antibodies. Bio-protocol 6(11): e1829. DOI: 10.21769/BioProtoc.1829.
分类
免疫学 > 抗体分析 > 抗体功能
您对这篇实验方法有问题吗?
在此处发布您的问题,我们将邀请本文作者来回答。同时,我们会将您的问题发布到Bio-protocol Exchange,以便寻求社区成员的帮助。
提问指南
+ 问题描述
写下详细的问题描述,包括所有有助于他人回答您问题的信息(例如实验过程、条件和相关图像等)。
Share
Bluesky
X
Copy link